echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Express Targeting mitochondria for cancer, Alzheimer's disease and Parkinson's disease! Xinrui completed a $72.5 million Series A financing round

    Express Targeting mitochondria for cancer, Alzheimer's disease and Parkinson's disease! Xinrui completed a $72.5 million Series A financing round

    • Last Update: 2022-09-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    ▎ WuXi AppTec content team editor

    Pretzel Therapeutics today announced the completion of a $72.




    The main function of mitochondria is to be responsible for producing the energy



    There are more than 50 disorders associated with mitochondrial dysfunction, the most serious of which is called mitochondrial disease, which occurs in about 1 in every 5,000 people, and these rare genetic diseases can affect patients



    Image credit: 123RF

    Pretzel's platform consists of three technologies that regulate mitochondrial function: genome correction, genome expression regulation, and mitochondrial quality control



    "We are excited to be a pioneer





    WuXi AppTec provides integrated, end-to-end new drug development and production services to the global biopharmaceutical industry, covering chemical drug development and production, biological research, preclinical and clinical trial development, cell and gene therapy research and development, testing and production


    ▲If you have any business needs, please long press to scan the QR code above, or

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.